Comparative Pharmacology
Head-to-head clinical analysis: OSMITROL 10 IN WATER IN PLASTIC CONTAINER versus OSMITROL 20 IN WATER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OSMITROL 10 IN WATER IN PLASTIC CONTAINER versus OSMITROL 20 IN WATER.
OSMITROL 10% IN WATER IN PLASTIC CONTAINER vs OSMITROL 20% IN WATER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Increases plasma osmolality, drawing water from tissues into the bloodstream, thereby reducing intracranial pressure and cerebral edema.
Osmotic diuretic that increases plasma osmolality, drawing water from intracellular spaces into extracellular fluid and increasing renal tubular osmotic pressure, which inhibits water reabsorption and promotes diuresis.
Initial: 0.25–1 g/kg (25–100 mL of 10% solution) IV over 30–60 minutes. May repeat every 6–12 hours if needed. Typical adult dose: 50–100 g IV. Maximum: 2 g/kg per dose.
1-2 g/kg (5-10 mL/kg of 20% solution) intravenously over 30-60 minutes for reduction of intracranial pressure; may repeat every 6-8 hours. For preoperative bowel preparation, 100-200 mL (20% solution) orally.
None Documented
None Documented
Terminal half-life approximately 1.5 hours in normal renal function; prolonged in renal impairment (up to 36 hours in anuria).
0.25–1.5 hours (15–90 minutes) in patients with normal renal function. In oliguric or anuric patients, half-life is markedly prolonged, up to 36 hours, due to reduced clearance.
Primarily renal; >90% excreted unchanged in urine via glomerular filtration; <5% biliary/fecal.
Primarily renal excretion as unchanged drug. Over 90% of administered dose is excreted unchanged in urine within 24 hours. Less than 5% is metabolized in the liver; negligible biliary/fecal elimination.
Category C
Category C
Osmotic Diuretic
Osmotic Diuretic